Evidence map›Paper›PMID 20705663›Full record

ArticleMicrobiology (Reading, England)2010

Heterogeneous distribution of Candida albicans cell-surface antigens demonstrated with an Als1-specific monoclonal antibody.

David A Coleman, Soon-Hwan Oh, Xiaomin Zhao, Lois L Hoyer

Open access · greenAbstract read
In one paragraph

Article in Microbiology (Reading, England), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Promising immunotherapeutic targets for treating candidiasis.Frontiers in cellular and infection microbiology · 2024
    Review
  4. Development and Use of a Monoclonal Antibody Specific for theFrontiers in cellular and infection microbiology · 2022
    Article
  5. Article
  6. Virulence · 2020
    Article
  7. Article
  8. Article
  9. Agglutinin-Like Sequence (Frontiers in microbiology · 2019
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

David A ColemanDepartment of Pathobiology, University of Illinois at Urbana-Champaign, Urbana, IL 61802, USA.
Soon-Hwan OhDepartment of Pathobiology, University of Illinois at Urbana-Champaign, Urbana, IL 61802, USA.
Xiaomin ZhaoDepartment of Pathobiology, University of Illinois at Urbana-Champaign, Urbana, IL 61802, USA.
Lois L HoyerDepartment of Pathobiology, University of Illinois at Urbana-Champaign, Urbana, IL 61802, USA.
University of Illinois Urbana-Champaign · US

Funding

THE ALS GENE FAMILY OF CANDIDA ALBICANSR01DE014158 · NIDCR · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI HOYER, LOIS L. · 2000 to 2010
$3.0M
UIUC COLLEGE VET MED COMPLETION SHELL SPACEC06RR016515 · NCRR · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI WHITELEY, HERBERT E · 2001 to 2001
$1.5M
NCRR NIH HHS C06 RR016515NCRR NIH HHS C06 RR16515-01NIDCR NIH HHS R01 DE014158NIDCR NIH HHS R01 DE14158
6 · The paper itself

Abstract

Despite an abundance of data describing expression of genes in the Candida albicans ALS (agglutinin-like sequence) gene family, little is known about the production of Als proteins on individual cells, their spatial localization or stability. Als proteins are most commonly discussed with respect to function in adhesion of C. albicans to host and abiotic surfaces. Development of a mAb specific for Als1, one of the eight large glycoproteins encoded by the ALS family, provided the opportunity to detect Als1 during growth of yeast and hyphae, both in vitro and in vivo, and to demonstrate the utility of the mAb in blocking C. albicans adhesion to host cells. Although most C. albicans yeast cells in a saturated culture are Als1-negative by indirect immunofluorescence, Als1 is detected on the surface of nearly all cells shortly after transfer into fresh growth medium. Als1 covers the yeast cell surface, with the exception of bud scars. Daughters of the inoculum cells, and sometimes granddaughters, also have detectable Als1, but Als1 is not detectable on cells from subsequent generations. On germ tubes and hyphae, most Als1 is localized proximal to the mother yeast. Once deposited on yeasts or hyphae, Als1 persists long after the culture has reached saturation. Growth stage-dependent production of Als1, coupled with its persistence on the cell surface, results in a heterogeneous population of cells within a C. albicans culture. Anti-Als1 immunolabelling patterns vary depending on the source of the C. albicans cells, with obvious differences between cells recovered from culture and those from a murine model of disseminated candidiasis. Results from this work highlight the temporal parallels for ALS1 expression and Als1 production in yeasts and germ tubes, the specialized spatial localization and persistence of Als1 on the C. albicans cell surface, and the differences in Als1 localization that occur in vitro and in vivo.

Indexed as

AnimalsAntibodies, MonoclonalAntigens, SurfaceCandida albicansCandidiasisCell LineFungal ProteinsGene Expression Regulation, DevelopmentalGene Expression Regulation, FungalHumansMiceMice, Inbred BALB CALS1 protein, Candida albicansAntibodies, MonoclonalAntigens, SurfaceFungal Proteins

Identifiers

PMID20705663
PMCPMC3068703
OpenAlexW2121894527

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.